Werewolf Therapeutics Inc [HOWL] stock prices are up 5.39% to $1.76 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HOWL shares have lost -6.38% over the last week, with a monthly amount glided 21.38%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Werewolf Therapeutics Inc [NASDAQ: HOWL] stock has seen the most recent analyst activity on April 03, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $12. Previously, Wedbush started tracking the stock with Outperform rating on August 24, 2023, and set its price target to $9. BofA Securities started tracking the stock assigning a Buy rating and suggested a price target of $26 on September 10, 2021. SVB Leerink initiated its recommendation with a Outperform and recommended $29 as its price target on May 25, 2021. Jefferies started tracking with a Buy rating for this stock on May 25, 2021, and assigned it a price target of $22. In a note dated May 25, 2021, H.C. Wainwright initiated a Buy rating and provided a target price of $32 on this stock.
The stock price of Werewolf Therapeutics Inc [HOWL] has been fluctuating between $0.60 and $4.18 over the past year. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Werewolf Therapeutics Inc [NASDAQ: HOWL] shares were valued at $1.76 at the most recent close of the market. An investor can expect a potential return of 581.82% based on the average HOWL price forecast.
Analyzing the HOWL fundamentals
The Werewolf Therapeutics Inc [NASDAQ:HOWL] reported sales of 0.00M for trailing twelve months, representing a drop of -100.00%. To continue investigating profitability, this company’s Return on Assets is posted at -0.79, Equity is -1.12 and Total Capital is -0.94. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Werewolf Therapeutics Inc [NASDAQ:HOWL]’s Current Ratio is 5.30. Also, the Quick Ratio is 5.30, while the Cash Ratio stands at 5.17.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on May 12 ’25 when 0.32 million shares were purchased. Director, RA CAPITAL MANAGEMENT, L.P. completed a deal on May 14 ’25 to buy 0.16 million shares. Meanwhile, Director RA CAPITAL MANAGEMENT, L.P. bought 52974.0 shares on May 13 ’25.
